(SOUNDBITE OF SONG, “AND THEN WHAT”)
JEEZY: (Singing) Let’s get it. First, I’m gone stack my flo’. And then what? Then I’m gone stack some mo’. And then what?
AYESHA RASCOE, HOST:
Twenty years ago, rapper Young Jeezy…
Author: admin
-
Punjab Sahulat Bazar Authority earns Int’l certifications – RADIO PAKISTAN
- Punjab Sahulat Bazar Authority earns Int’l certifications RADIO PAKISTAN
- Punjab Sahulat Bazaars Authority receives international certifications Profit by Pakistan Today
- Punjab CM expresses happiness: Bazaar Authority to get ISO 901 & ISO 27001…
Continue Reading
-
Vitexin induces apoptosis and enhances daunorubicin efficacy in acute leukemia via modulation of the HIF-1α/Bcl-2/caspase-3 pathway
Arber, D. A. et al. International consensus classification of myeloid neoplasms and acute leukemias: integrating morphologic clinical and genomic data. Blood 140(11), 1200–1228 (2022).
Chennamadhavuni, A., Iyengar, V., Mukkamalla, S. K. R. & Shimanovsky, A. Leukemia. StatPearls. Treasure Island (FL): StatPearls Publishing, Copyright © 2024 (StatPearls Publishing LLC, 2025).
Churpek, J. E. Familial myelodysplastic syndrome/acute myeloid leukemia. Best Pract. Res. Clin. Haematol. 30(4), 287–289 (2017).
Arbuckle, C. Exploring the use of alternative diets in people living with cancer. Nurs. Stand. 38(3), 63–68 (2023).
Harris, P. E., Cooper, K. L., Relton, C. & Thomas, K. J. Prevalence of complementary and alternative medicine (CAM) use by the general population: a systematic review and update. Int. J. Clin. Pract. 66(10), 924–939 (2012).
Matriz, J., Hamachi, A. & Fukui, J. A. The use of complementary and alternative medicine (CAM) among patients with cancer in Hawaii. J. Clin. Oncol. 42(16_suppl), e24070–e (2024).
Posadzki, P., Watson, L. K., Alotaibi, A. & Ernst, E. Prevalence of use of complementary and alternative medicine (CAM) by patients/consumers in the UK: systematic review of surveys. Clin. Med. (Lond). 13(2), 126–131 (2013).
Yousefi, M., Reihani, H., Heydari, M., Nasimi Doost Azgomi, R. & Hashempur, M. H. Complementary and alternative medicine use among cancer patients in Iran: A systematic review. Prev. Med. Rep. 39, 102644 (2024).
Ketelut-Carneiro, N. & Fitzgerald, K. A. Apoptosis, pyroptosis, and necroptosis-oh my! The many ways a cell can die. J. Mol. Biol. 434(4), 167378 (2022).
Elmore, S. Apoptosis: a review of programmed cell death. Toxicol. Pathol. 35(4), 495–516 (2007).
Shen, S., Shao, Y. & Li, C. Different types of cell death and their shift in shaping disease. Cell. Death Discov. 9(1), 284 (2023).
Alberts, B. J. A. et al. Programmed Cell Death (Apoptosis). 4th edition ed: Molecular Biology of the Cell. (2002).
Booth, L. A., Tavallai, S., Hamed, H. A., Cruickshanks, N. & Dent, P. The role of cell signalling in the crosstalk between autophagy and apoptosis. Cell. Signal. 26(3), 549–555 (2014).
Karmakar, U. et al. Immune complex-induced apoptosis and concurrent immune complex clearance are anti-inflammatory neutrophil functions. Cell. Death Dis. 12(4), 296 (2021).
Tait, S. W. & Green, D. R. Mitochondria and cell death: outer membrane permeabilization and beyond. Nat. Rev. Mol. Cell. Biol. 11(9), 621–632 (2010).
Yutharaksanukul, P. et al. Effects of purified vitexin and iso-vitexin from mung bean seed coat on antihyperglycemic activity and gut microbiota in overweight individuals’ modulation. Nutrients. 16(17) (2024).
Maneewan, S., Tangpromphan, P. & Jaree, A. Separation of vitexin and Iso-vitexin from mung bean seed coats using a three-zone simulated moving bed (SMB). Waste Biomass Valoriz. 12(12), 6601–6618 (2021).
Liu, X., Jiang, Q., Liu, H. & Luo, S. Vitexin induces apoptosis through mitochondrial pathway and PI3K/Akt/mTOR signaling in human non-small cell lung cancer A549 cells. Biol. Res. 52(1), 7 (2019).
Najafipour, R., Momeni, A. M., Mirmazloomi, Y. & Moghbelinejad, S. Vitexin induces apoptosis in MCF-7 breast cancer cells through the regulation of specific MiRNAs expression. Int. J. Mol. Cell. Med. 11(3), 197–206 (2022).
Bhardwaj, M. et al. Vitexin induces apoptosis by suppressing autophagy in multi-drug resistant colorectal cancer cells. Oncotarget 9(3), 3278–3291 (2018).
Zhou, P. et al. Vitexin inhibits gastric cancer growth and metastasis through HMGB1-mediated inactivation of the PI3K/AKT/mTOR/HIF-1alpha signaling pathway. J. Gastric Cancer. 21(4), 439–456 (2021).
Mubeen, M., Ali, H., Zehra, S. S. & Khan, A. Harnessing the power of vitexin as a vitamin D receptor agonist in colorectal cancer: A new frontier. Balkan Med. J. 42(3), 276–278 (2025).
Khoja, K. K. et al. Cytotoxicity of fenugreek sprout and seed extracts and their bioactive constituents on MCF-7 breast cancer cells. Nutrients. 14(4) (2022).
Ganesan, K. & Xu, B. Molecular targets of vitexin and isovitexin in cancer therapy: a critical review. Ann. N Y Acad. Sci. 1401(1), 102–113 (2017).
Sarkar, M. K., Mahapatra, S. K. & Vadivel, V. Oxidative stress mediated cytotoxicity in leukemia cells induced by active phyto-constituents isolated from traditional herbal drugs of West Bengal. J. Ethnopharmacol. 251, 112527 (2020).
Sarkar, M. K., Kar, A., Jayaraman, A., Kar Mahapatra, S. & Vadivel, V. Vitexin isolated from prosopis cineraria leaves induce apoptosis in K-562 leukemia cells via Inhibition of the BCR-ABL-Ras-Raf pathway. J. Pharm. Pharmacol. 74(1), 103–111 (2022).
Liang, C., Jiang, Y. & Sun, L. Vitexin suppresses the proliferation, angiogenesis and stemness of endometrial cancer through the PI3K/AKT pathway. Pharm. Biol. 61(1), 581–589 (2023).
Zhou, Y. et al. Vitexins, nature-derived lignan compounds, induce apoptosis and suppress tumor growth. Clin. Cancer Res. 15(16), 5161–5169 (2009).
Al-Aamri, H. M. et al. Time dependent response of daunorubicin on cytotoxicity, cell cycle and DNA repair in acute lymphoblastic leukaemia. BMC Cancer. 19(1), 179 (2019).
Kantarjian, H. M., Kadia, T. M., DiNardo, C. D., Welch, M. A. & Ravandi, F. Acute myeloid leukemia: treatment and research outlook for 2021 and the MD Anderson approach. Cancer 127(8), 1186–1207 (2021).
Rowe, J. M. The 7 + 3 regimen in acute myeloid leukemia. Haematologica 107(1), 3 (2022).
Sarkar, M. K., Vadivel, V., Raja, M. R. C. & Kar Mahapatra, S. Investigation of phytochemical constituents of anti-leukemic herbal drugs used by the traditional healers of Purulia, Birbhum and Bankura districts of West Bengal. Nat. Prod. Res. 34(23), 3388–3393 (2020).
Ullah, A. et al. Important flavonoids and their role as a therapeutic agent. Molecules 25(22), 5243 (2020).
Chou, T. C. Drug combination studies and their synergy quantification using the Chou-Talalay method. Cancer Res. 70(2), 440–446 (2010).
Continue Reading
-
How Social Media Shapes Children’s Attention Over Time
NEW research from a major USA child-development study suggests that daily social media use, though often dismissed as harmless, may contribute to small but measurable increases in inattention symptoms over time. The findings, drawn from more…
Continue Reading
-
Nanit Home Display Review: A Transformative Tablet
Photograph: Nicole Kinning
The Home monitor can run wirelessly and charges via a USB-C cable. It relies on your Wi-Fi network to connect to the camera, so while you can carry the monitor around your home, you can’t take it fully “off-grid”…
Continue Reading
-
ICYMI: Highlights From AACR 2025
Each year, certain developments in oncology rise above the rest—either for their clinical impact, their potential to shift standards of care, or simply because they capture the imagination of clinicians, researchers, and patients alike. In 2025, readers gravitated toward stories spanning cutting-edge immunotherapy, emerging targets like RAS, lifestyle-related cancer risks, and promising early-phase science presented at the American Association for Cancer Research (AACR) meeting.
Here are the 5 most-viewed
AACR pieces of 2025.5. Proving the Concept: A Sampler of Early-Stage Science at AACR 2025
Among the standout developments were SENTI-202, an off-the-shelf chimeric antigen receptor natural killer–cell therapy that produced complete remissions in a subset of patients with relapsed or refractory acute myeloid leukemia, and CHS-114, a novel antibody targeting CCR8-positive regulatory T cells with the potential to reprogram the tumor microenvironment in head-and-neck cancers. The roundup also featured encouraging data on micvotabart pelidotin, an antibody–drug conjugate that targets the EDB+ fibronectin domain to disrupt tumor structure across several solid tumors. Collectively, these early signals offer more than incremental progress. they represent concept-proving science with the potential to redefine treatment approaches in the years ahead.
Read the full article. 4. From “Super-Skeptical” Beginnings, a New Immune-Modulatory Vaccine Awaits Phase 3 Results
This piece explored the development of an immunomodulatory vaccine designed not to prevent disease but to reshape immune responses against existing conditions—a departure from traditional vaccine use. Its move toward phase 3 trials speaks to the broader shift in oncology to harnessing and recalibrating the immune system in increasingly sophisticated ways. The article tracked how therapeutic vaccines might complement or even enhance established modalities like checkpoint blockade and adoptive cell therapy. With a pivotal trial now underway, many are waiting to see whether the early promise can translate into durable, clinically meaningful benefit.
Read the full article. 3. Addressing KRAS Resistance: RAS(ON) Therapies Find Limelight at AACR
The long-standing challenge of targeting KRAS—once considered undruggable—remains a focal point of oncology research. The AACR 2025 updates on “RAS-(ON)” inhibitors, which aim to neutralize active forms of the protein driving tumor growth, struck a chord with oncologists who routinely confront KRAS-mutant cancers in the clinic. As RAS-targeting strategies expand and mature, the article highlighted a path toward more effective options for patients with KRAS-driven lung, colorectal, pancreatic, and other malignancies.
Read the full article. 2. Ultraprocessed Foods Tied to Higher Cancer Risk
This interview spotlighted new epidemiologic findings linking high consumption of ultraprocessed foods with an elevated risk of developing cancer, drawing in clinicians, researchers, and consumers interested in the intersection of diet and cancer prevention. The analysis presented by Mingyang Song, MBBS, ScD, Harvard T.H. Chan School of Public Health, emphasized that although the overall association is statistically modest, the relationship appears consistent—particularly for colorectal cancer among men. This interview reflects rising awareness of lifestyle factors in cancer risk, as well as an appetite for clearer guidance on how diet contributes to long-term health outcomes.
Watch the full interview. 1. Patients With Multiple Types of Mismatch Repair–Deficient Tumors Avoid Surgery With Dostarlimab
This year’s most-read story detailed a landmark phase 2 trial showing that patients with mismatch repair–deficient (dMMR) solid tumors achieved high rates of complete clinical response with dostarlimab, allowing many to forgo surgery entirely. The findings—82% complete response among evaluable patients and 92% recurrence-free survival at 2 years—captivated readers because they signal a potential paradigm shift in how dMMR tumors are managed across gastrointestinal and urothelial cancers. As early-onset gastrointestinal cancers continue to rise, the article highlighted a future in which immunotherapy-first strategies may offer curative outcomes without the morbidity of traditional operative approaches.
Read the full article. Continue Reading
-
Little Foot hominin fossil may be new species of human ancestor | Evolution
Little Foot, one of the world’s most complete hominin fossils, may be a new species of human ancestor, according to research that raises questions about our evolutionary past.
Publicly unveiled in 2017, Little Foot is the most complete…
Continue Reading
-
Bluey’s Quest for the Gold Pen: after some misfires we finally have the first good Bluey video game | Games
Bluey embodies the talent, heart and character of Australia’s creative industries. But unfortunately, until now, the beloved franchise’s video games had a track record spottier than her friend Chloe the dalmatian.
Some parents treated Budge…
Continue Reading
-
Brazil’s lagoon-filled desert you can hike barefoot
His pride was unmistakable. “This is my home, my office, my place in the world,” he told me. That sense of belonging, he said, is what brings him back season after season. “We need to turn our attention back to the traditional communities….
Continue Reading
-
We think we found the most active Waymo rider in SF. Prove us wrong.
Waymo users who logged more than three rides in 2025 received a reward from the robotaxi company: a personalized “Year in Review.” Think of it as a Spotify-style Waymo Wrapped, tallying up your trips and assigning a “Waymotype,” such as…
Continue Reading